A Study for Patients With Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to test the hypothesis that 1 or more dose levels of LY2140023 given orally to patients with schizophrenia twice daily for 4 weeks will have significantly greater effect than placebo.
Epistemonikos ID: 22e989c4adfe4c85cd7c94642ced2d548d746041
First added on: May 04, 2024